PMA P130016S058

Device
Nucleus® Hybrid™ L24 Cochlear Implant System
Applicant
Cochlear Americas
PMA number
P130016
Supplement
S058
Product code
PGQ
Decision date
2025-10-16
Classification
Ear, Nose, Throat
Generic name
Cochlear implant with combined electrical stimulation and acoustic amplification
Approval order statement
Cochlear™ ECochG Measures v3.0 software module within the Cochlear™ Clinical Extension Platform, to provide compatibility with devices approved under P970051/S225 (CI1000 Series implants, CP1110 Sound Processor, and CP1110S Surgical Processor) and existing acoustic components used with these new devices, in addition to devices already compatible with v2.0. The name of the software module is also changed from v2.0 Cochlear Research Platform ECochG Software module (within Cochlear Research Platform) to v3.0 Cochlear ECochG Measures module (within Cochlear Clinical Extension Platform).

Current openFDA PMA Record#

Device
Nucleus® Hybrid™ L24 Cochlear Implant System
Applicant
Cochlear Americas
PMA number
P130016
Supplement
S058
Product code
PGQ
Generic name
Cochlear implant with combined electrical stimulation and acoustic amplification
Decision date
2025-10-16
Decision code
APPR
Date received
2025-07-21
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Cochlear™ ECochG Measures v3.0 software module within the Cochlear™ Clinical Extension Platform, to provide compatibility with devices approved under P970051/S225 (CI1000 Series implants, CP1110 Sound Processor, and CP1110S Surgical Processor) and existing acoustic components used with these new devices, in addition to devices already compatible with v2.0. The name of the software module is also changed from v2.0 Cochlear Research Platform ECochG Software module (within Cochlear Research Platform) to v3.0 Cochlear ECochG Measures module (within Cochlear Clinical Extension Platform).